United States 117th Congress Status: In Committee Bipartisan · 34 D · 3 I cosponsors

S 3700 — Affordable Insulin Now Act

Last action — Read twice and referred to the Committee on Finance.

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 117th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Affordable Insulin Now Act This bill limits cost-sharing for insulin under private health insurance and the Medicare prescription drug benefit. Specifically, the bill caps cost-sharing under private health insurance for a month's supply of selected insulin products at $35 or 25% of a plan's negotiated price (after any price concessions), whichever is less, beginning in 2023. The bill caps cost-sharing under the Medicare prescription drug benefit for a month's supply of covered insulin products at (1) $35 between October 1, 2022, and January 1, 2024; and (2) $35 or 25% of a plan's negotiated price, whichever is less, beginning in 2024. The bill provides funds for FY2022 for the Centers for Medicare & Medicaid Services (CMS) to implement the bill. Currently, the CMS is testing a voluntary model under the Medicare prescription drug benefit (the Part D Senior Savings Model) in which the copayment for a month's supply of insulin is capped at $35 through participating plans. The model is set to expire on December 31, 2025.

Bill Text

How this bill changes current law

13 changes Share ↗

Compared against current U.S. Code AI-generated reading aid — verify against the official bill.

The bill establishes new cost-sharing requirements for insulin products under Medicare Part D and private health plans.

  • 42 U.S.C. 1395w-102

    The coverage → Subject to paragraph (8), the coverage

    The bill specifies that coverage for insulin products is subject to new cost-sharing rules.

  • 42 U.S.C. 1395w-102

    and (D) → and (D) and paragraph (8)

    This change incorporates the new insulin cost-sharing provisions into existing coverage requirements.

  • 42 U.S.C. 1395w-102

    paragraph (4) → paragraphs (4) and (8)

    This amendment updates references to include the new cost-sharing rules for insulin products.

  • 42 U.S.C. 1395w-102

    paragraph (4) → paragraphs (4) and (8)

    This ensures that the new insulin cost-sharing rules apply alongside existing rules.

  • 42 U.S.C. 1395w-102

    and (4) → (4), and (8)

    This addition reinforces that insulin products will follow the new cost-sharing guidelines.

  • 42 U.S.C. 1395w-102

    The coverage → Subject to paragraph (8), the coverage

    Establishes framework for cost-sharing for insulin products under Medicare.

  • 42 U.S.C. 1395w-102

    paragraph (4) → paragraphs (4) and (8)

    Incorporates insulin product cost-sharing provisions into existing coverage rules.

  • 42 U.S.C. 1395w-102

    covered insulin product → covered insulin product (as defined in subparagraph (B))

    Clarifies the definition of covered insulin products in relation to cost-sharing.

  • 42 U.S.C. 1395w-114

    amount applicable under the preceding sentence → the copayment amount applicable under the preceding sentence to a month's supply of a covered insulin product (as described in section 1860D-2(b)(8))

    Ensures that copayments for low-income individuals for insulin do not exceed new limits.

  • 42 U.S.C. 1395w-114

    applicable copayment or coinsurance amount → applicable copayment or coinsurance amount for the product under the prescription drug plan or MA-PD plan in which the individual is enrolled.

    Aligns cost-sharing for low-income individuals with the insulin coverage provisions.

  • 42 U.S.C. 300gg-111

    SEC. 2799A-11. REQUIREMENTS WITH RESPECT TO COST-SHARING FOR CERTAIN INSULIN PRODUCTS.

    Introduces a new section to regulate cost-sharing for insulin products under private health plans.

  • 42 U.S.C. 300gg-111

    For plan years beginning on or after January 1, 2023, a group health plan or health insurance issuer offering group or individual health insurance coverage shall provide coverage of selected insulin products.

    Mandates coverage of selected insulin products under private health plans.

  • 42 U.S.C. 18022

    Special rule relating to insulin coverage.

    Establishes special rules for insulin coverage that impact actuarial value calculations.

Action History

  1. Introduced in Senate

  2. Read twice and referred to the Committee on Finance.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 36 co-sponsors · 510 not signed on

Sponsors (1)

Co-sponsors (36)

Not signed on (510)

510 members have not signed on to this bill.

Show all 510 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does S 3700 do?
Affordable Insulin Now Act This bill limits cost-sharing for insulin under private health insurance and the Medicare prescription drug benefit. Specifically, the bill caps cost-sharing under private health insurance for a month's supply of selected insulin products at $35 or 25% of a plan's negotiated price (after any price concessions), whichever is less, beginning in 2023. The bill caps cost-sharing under the Medicare prescription drug benefit for a month's supply of covered insulin products at (1) $35 between October 1, 2022, and January 1, 2024; and (2) $35 or 25% of a plan's negotiated price, whichever is less, beginning in 2024. The bill provides funds for FY2022 for the Centers for Medicare & Medicaid Services (CMS) to implement the bill. Currently, the CMS is testing a voluntary model under the Medicare prescription drug benefit (the Part D Senior Savings Model) in which the copayment for a month's supply of insulin is capped at $35 through participating plans. The model is set to expire on December 31, 2025.
Who sponsors S 3700?
S 3700 is sponsored by Schumer, Charles E. (Democratic), Durbin, Richard J. (Democratic), Wyden, Ron (Democratic), Bennet, Michael F. (Democratic), Blumenthal, Richard (Democratic), Baldwin, Tammy (Democratic), Kelly, Mark (Democratic), Stabenow, Debbie (Democratic), Reed, Jack (Democratic), Van Hollen, Chris (Democratic), Hirono, Mazie K. (Democratic), Klobuchar, Amy (Democratic), Murphy, Christopher (Democratic), Hassan, Margaret Wood (Democratic), Shaheen, Jeanne (Democratic), Booker, Cory A. (Democratic), King, Angus S., Jr. (Independent), Smith, Tina (Democratic), Padilla, Alex (Democratic), Peters, Gary C. (Democratic), Whitehouse, Sheldon (Democratic), Rosen, Jacky (Democratic), Brown, Sherrod (Democratic), Cortez Masto, Catherine (Democratic), Manchin, Joe, III (Independent), Merkley, Jeff (Democratic), Hickenlooper, John W. (Democratic), Menendez, Robert (Democratic), Casey, Robert P., Jr. (Democratic), Sinema, Kyrsten (Independent), Duckworth, Tammy (Democratic), Heinrich, Martin (Democratic), Feinstein, Dianne (Democratic), Kaine, Tim (Democratic), Luján, Ben Ray (Democratic), Carper, Thomas R. (Democratic), and Warnock, Raphael G. (Democratic).
What is the current status of S 3700?
This bill died with 117th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track S 3700?
Track S 3700 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on S 3700

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of S 3700

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →